Tag: weight loss
-

India’s Doctors Sound Alarm Over Unregulated Weight Loss Injections
Rising demand for weight loss injections sparks concern Across India, a rapid surge in demand for appetite-suppressing injections has caught the attention of healthcare professionals. While some clinics market these injections as quick fixes for weight loss, doctors warn that the unregulated market is creating serious safety gaps. Experts say there is a growing disconnect…
-

From Hurtful Words to Transformative Weight Loss: A Woman’s 20kg Journey and a Surprising Joey Wong Doppelgänger Moment
Turning Negative Commentary into a Wellness Drive What begins as a cruel remark can sometimes spark a life-changing decision. In this reported case, a woman from Hubei, China, known publicly as Liu Xiaodi on social media, says she was told she was “fat and ugly” by a popular celebrity. The words, though hurtful, became a…
-

From Fat-Shaming to Fitness Triumph: How a Celebrity Snide Remark Fueled a 20kg Weight Loss and a New Look Alike to Joey Wong
Turning Negativity into Motivation: The Beginning of a Transformation In an era where personal narratives often go viral, a story from Hubei has captured attention for its resilience. A woman, identified as Liu Xiaodi on social platforms, shared how a cutting remark from a well-known celebrity — accusing her of being fat and ugly —…
-

Exclusive: Fears over teenagers easy access to weight-loss drugs
Overview Health authorities and doctors are sounding the alarm over a surge in teenagers being referred to specialists after turning to weight-loss drugs they bought online. An exclusive investigation by Extra.ie reveals a growing pattern in which young people access pharmaceutical products not prescribed to them, prompting concern about safety, legality, and long-term health effects.…
-

Drugs Without Nausea: Scientists Target Brain Circuits to Separate Side Effects from Weight-Loss Benefits
Overview: Aiming for Nausea-Free Weight-Loss Drugs Nausea has long been a common hurdle for people using weight-loss medications such as Ozempic and other GLP-1 receptor agonists. While these drugs can help curb appetite and promote weight loss, the unpleasant side effect of nausea can limit adherence and diminish quality of life. In response, scientists are…
-

Drugs Without Nausea: Scientists Target Brain to Separate Side Effects
Overview: Aiming to keep the appetite, not the nausea Nausea is a common hurdle for millions using modern weight-loss medications, from GLP-1 receptor agonists to newer formulations. As scientists race to expand the benefits of these drugs, a central question guides the research: can the brain’s pathways be fine-tuned so that the appetite-suppressing effects remain,…
-

Can Weight-Loss Drugs Be Nausea-Free? Scientists Target Brain Pathways
Can weight-loss drugs be nausea-free? For millions of people seeking safer and more tolerable weight-loss options, the promise of nausea-free medications is steadily moving from rumor to research reality. Drugs like Ozempic (semaglutide) and other GLP-1 receptor agonists have helped many shed pounds by suppressing appetite and improving metabolic health. But side effects—especially nausea, vomiting,…
-

Overcoming Nausea: The Next Wave of Weight-Loss Drugs and Safer Experiences
Search for a ‘painless’ path to weight loss Millions of Americans have found success with prescription medications like Wegovy and Zepbound, which help reduce appetite and boost weight loss. Yet the journey isn’t the same for everyone. A common obstacle is nausea, a side effect that can range from mild discomfort to significant disruption in…
-

Brain scientists pursue nausea-free weight-loss drugs amid GLP-1 breakthroughs
Overview: The quest for nausea-free weight-loss medications Millions of Americans have achieved impressive weight loss with medications such as Wegovy and Zepbound, which target the body’s GLP-1 pathways to curb appetite and boost metabolic effects. Yet the journey with these drugs isn’t without rough edges. Nausea, vomiting, and other gastrointestinal side effects remain common early…

